IS DUAL AGENT IMMUNOTHERAPY SHIFTING THE EPIDEMIOLOGY OF MELANOMA BRAIN METASTASES? A REAL-WORLD ANALYSIS AND SINGLE-INSTITUTION VALIDATION

被引:0
|
作者
Bhanja, Debarati [1 ]
Wilding, Hannah [2 ]
Moeckel, Camille [3 ]
Hong, Jinpyo [3 ]
Baroz, Angel [3 ]
Stahl, Caleb [3 ]
Ozair, Ahmad [4 ]
Dao, Joseph [3 ]
Sivik, Jeff [3 ]
Drabick, Joseph [3 ]
Pameijer, Colette [3 ]
Ahluwalia, Manmeet [5 ]
Mansouri, Alireza [2 ]
机构
[1] Penn State Coll Med, New York, NY USA
[2] Penn State Hershey Med Ctr, Hershey, PA USA
[3] Penn State Coll Med, Hershey, PA USA
[4] Miami Baptist Hlth, Miami, FL USA
[5] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMMU-02
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Real-world experience of combined ipilimumab and nivolumab for advanced melanoma in a single UK institution
    Boon, Ian S.
    Marples, Maria
    CLINICAL ONCOLOGY, 2018, 30 : E2 - E2
  • [22] Reduction of subclinical acute cardiac injury through DIBH radiotherapy: a single-institution real-world clinical cohort analysis
    Zhang, Kun
    Shen, Jing
    Liang, Yongguang
    Meng, Xiangyin
    Yang, Bo
    Ma, Jiabin
    Hu, Ke
    Qiu, Jie
    Hou, Xiaorong
    Zhang, Fuquan
    BMC CANCER, 2025, 25 (01)
  • [23] Analysis of real-world outcomes of IKZFmut in Philadelphia chromosome-positive ALL: A retrospective, single-institution experience.
    Zacholski, Kyle
    Bouligny, Ian Michael
    Venn, Chad Michael
    Tran, Valerie
    Alnimer, Yanal Mufeed
    Ho, Thuy
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19032 - E19032
  • [24] Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
    Yang Wang
    Bin Lian
    Lu Si
    ZhiHong Chi
    XiNan Sheng
    Xuan Wang
    LiLi Mao
    BiXia Tang
    SiMing Li
    XieQiao Yan
    Xue Bai
    Li Zhou
    ChuanLiang Cui
    Jun Guo
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2731 - 2740
  • [25] Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases
    Berking, C.
    Schadendorf, D.
    Weichenthal, M.
    Eigentler, T.
    Mohr, P.
    Schober, K.
    Kiecker, F.
    Loquai, C.
    Debus, D.
    Gutzmer, R.
    Leiter-Stoeppke, U.
    ANNALS OF ONCOLOGY, 2020, 31 : S755 - S755
  • [26] Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
    Wang, Yang
    Lian, Bin
    Si, Lu
    Chi, ZhiHong
    Sheng, XiNan
    Wang, Xuan
    Mao, LiLi
    Tang, BiXia
    Li, SiMing
    Yan, XieQiao
    Bai, Xue
    Zhou, Li
    Cui, ChuanLiang
    Guo, Jun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2731 - 2740
  • [27] Real-World Vinflunine Outcomes in Bladder Cancer in a Single-Institution Study: Moving Beyond Clinical Trials
    Moriceau, Guillaume
    Vallard, Alexis
    Rivoirard, Romain
    Mery, Benoite
    Espenel, Sophie
    Langrand-Escure, Julien
    Ben Mrad, Majed
    Wang, Guoping
    Diao, Peng
    Pacaut, Cecile
    Guillot, Aline
    Collard, Olivier
    Fournel, Pierre
    Magne, Nicolas
    CLINICAL GENITOURINARY CANCER, 2015, 13 (06) : 588 - 592
  • [28] Examining the real-world utility of immune checkpoint inhibitors in genitourinary oncology: A single-institution retrospective.
    Glick, Lydia
    Clark, Cassra
    Han, Timothy M.
    Mark, James Ryan
    Gomella, Leonard G.
    Handley, Nathan
    Kelly, William Kevin
    Trabulsi, Edouard John
    Lallas, Costas D.
    Chandrasekar, Thenappan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan
    Kunimasa, Kei
    Sugimoto, Naotoshi
    Yamasaki, Tomoyuki
    Kukita, Yoji
    Fujisawa, Fumie
    Inoue, Tazuko
    Yamaguchi, Yuko
    Kitasaka, Mitsuko
    Sakai, Daisuke
    Honma, Keiichiro
    Wakamatsu, Toru
    Yamamoto, Sachiko
    Hayashi, Takuji
    Mabuchi, Seiji
    Okuno, Jun
    Kawamura, Takahisa
    Kai, Yugo
    Urabe, Makiko
    Nishimura, Kazuo
    CANCER MEDICINE, 2024, 13 (18):
  • [30] Impact of cranial stereotactic radiotherapy associated with immunotherapy with nivolumab and ipilimumab on overall survival in patients with melanoma brain metastases: a real-world evidence
    Douglas Guedes de Castro
    Carlos Henrique Andrade Teixeira
    Guilherme Rocha Melo Gondim
    Patrícia Bailão Aguilar
    Marcos André de Sá Barreto Costa
    Thiago William Carnier Jorge
    Rodrigo de Morais Hanriot
    Clinical and Translational Oncology, 2022, 24 : 1828 - 1830